Primary cutaneous anaplastic large-cell lymphoma successfully treated with intralesional brentuximab vedotin: a case report

被引：2
|
作者：
Arroyo-Andres, Jorge [1 ]
Agud-Dios, Manuel [1 ]
Rubio-Muniz, Carmen A. [1 ]
Vico-Alonso, Cristina [1 ]
Cortijo-Cascajares, Susana [2 ]
Ortiz-Romero, Pablo L. [1 ]
机构：
[1] Univ Complutense, 12 Octubre Hosp, Sch Med, CIBERONC,Dept Dermatol,Inst I 12, Madrid, Spain
[2] 12 Octubre Univ Hosp, Pharm Dept, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2022年 / 61卷 / 07期
关键词：
PAPULOSIS;
D O I：
10.1111/ijd.15834
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E267 / E269
页数：3
相关论文
共 50 条
  • [21] Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma
    Chen, Robert
    Allibone, Suzanne
    Bartlett, Nancy L.
    Brice, Pauline
    Chen, Andy
    Pose, Katrina
    Rich, Lynn
    Bonthapally, Vijay
    Garfin, Phillip M.
    Fanale, Michelle
    ONCOTARGETS AND THERAPY, 2016, 9 : 2027 - 2034
  • [22] Brentuximab vedotin: treatment role for relapsed refractory systemic anaplastic large-cell lymphoma
    Lai, Chao-Ming
    Horowitz, Sandra
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 361 - 373
  • [23] Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma
    Alderuccio, Juan Pablo
    Desai, Amrita
    Yepes, Monica M.
    Chapman, Jennifer R.
    Vega, Francisco
    Lossos, Izidore S.
    CLINICAL CASE REPORTS, 2018, 6 (04): : 634 - 637
  • [24] BRENTUXIMAB VEDOTIN DESENSITIZATION IN A FEMALE WITH RELAPSED, REFRACTORY, ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
    Qamar, N.
    Cho, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A68 - A68
  • [25] Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients
    Monjanel, Helene
    Deville, Laure
    Ram-Wolff, Caroline
    Venon, Marie-Dominique
    Franchi, Patricia
    Benet, Claire
    de Kerviler, Eric
    Malphettes, Marion
    Thieblemont, Catherine
    Brice, Pauline
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (02) : 306 - +
  • [26] Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin
    Milan, Elisa
    Miceli, Paola
    Sernicola, Alvise
    Finotto, Silvia
    Marino, Dario
    Alaibac, Mauro
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (06)
  • [27] Primary Cutaneous Anaplastic Large-Cell Lymphoma of the Eyelid
    Koestinger, Armin
    McKelvie, Penny
    McNab, Alan
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 28 (01): : E19 - E21
  • [28] Primary Cutaneous Sarcomatoid Anaplastic Large-Cell Lymphoma
    Bassett, Katrina
    Stutz, Nathalie
    Stenstrom, Melissa L.
    Wood, Gary S.
    Fleming, Matthew G.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (03) : 301 - 304
  • [29] Brentuximab Vedotin in primary cutaneous CD30+large-cell anaplastic T-Cell Lymphoma
    Moritz, R. K. C.
    Patsinakidis, N.
    Terras, S.
    Moellenhoff, K.
    Gambichler, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 921 - 921
  • [30] Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report
    Yan, Xiaohan
    Ren, Wenhao
    Li, Shaoming
    Zhu, Zhuang
    Gao, Ling
    Zhi, Keqian
    BMC ORAL HEALTH, 2024, 24 (01)
12345